James Patrick Tursi is Director of NeuroBo Pharmaceuticals, Inc.. Currently has a direct ownership of 37,219 shares of NRBO, which is worth approximately $60,666. The most recent transaction as insider was on Jun 30, 2025, when has been sold 28,147 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.2K
310.26% 3M change
310.26% 12M change
Total Value Held $60,666

James Patrick Tursi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
BUY
Grant, award, or other acquisition
-
28,147 Added 43.06%
37,219 Common Stock
Jun 07 2024
BUY
Grant, award, or other acquisition
-
5,051 Added 35.76%
9,072 Common Stock
Dec 01 2023
BUY
Grant, award, or other acquisition
-
32,157 Added 50.0%
32,157 Common Stock

Also insider at

AGRX
AGILE THERAPEUTICS INC Healthcare
ENDP
Endo International plc Healthcare
JPT

James Patrick Tursi

Director
Ballsbridge, Dublin, L2

Track Institutional and Insider Activities on NRBO

Follow NeuroBo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRBO shares.

Notify only if

Insider Trading

Get notified when an Neuro Bo Pharmaceuticals, Inc. insider buys or sells NRBO shares.

Notify only if

News

Receive news related to NeuroBo Pharmaceuticals, Inc.

Track Activities on NRBO